Jul 29, 2026 08:00AM

Jul 27, 2026 08:00AM

Jul 21, 2026 08:02AM

Jul 21, 2026 08:00AM

Jul 15, 2026 08:00AM

May 27, 2026 08:00AM

May 13, 2026 10:11AM PharmaTher's Sairiyo Therapeutics to Explore PD-001, Its Patented Reformulated Cepharanthine, for Hantavirus

May 13, 2026 08:50AM

Apr 21, 2026 08:00AM

Apr 20, 2026 08:00AM

Apr 16, 2026 08:00AM

Apr 13, 2026 08:00AM

Mar 26, 2026 08:00AM

Mar 3, 2026 08:00AM PharmaTher Expands PharmaPatch Delivery Platform into Therapeutic Peptides for the U.S. Market

Feb 2, 2026 09:27AM

Jan 14, 2026 08:00AM

Jan 2, 2026 08:00AM

Dec 2, 2025 09:53AM

Nov 17, 2025 08:00AM

Oct 17, 2025 08:26AM

Oct 16, 2025 08:04AM PharmaTher prepares FDA package for ketamine Phase 3 Parkinson's study

Oct 16, 2025 08:00AM

Oct 15, 2025 08:00AM

Oct 8, 2025 08:00AM

Aug 27, 2025 08:00AM

Aug 14, 2025 08:02AM

Aug 14, 2025 08:00AM

Aug 11, 2025 09:51AM PharmaTher receives FDA approval for ketamine product KETARx

Aug 11, 2025 09:49AM

Mar 3, 2025 08:00AM

Oct 31, 2024 08:58AM

Sep 19, 2024 08:00AM

Aug 28, 2024 08:00AM

Aug 21, 2024 09:52AM

Aug 19, 2024 08:00AM PharmaDrug's Sairiyo Therapuetics Receives Approval to Initiate Phase 1 Clinical Trial of Patented Reformulated Cepharanthine

443,750 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All